Navigation Links
A Vaccine for the impending pandemic Avian Influenza

All influenza viruses of the type A, including those causing seasonal epidemics of human influenza//, are genetically labile and well adapted to elude host defenses. The tendency of influenza viruses to undergo frequent and permanent antigenic changes necessitates constant monitoring of the global influenza situation and annual adjustments in the composition of influenza vaccines. Due to this tendency of mutation, avian influenza mixed with a human flu, and was thus able to infect humans through direct contact with birds.

According to the World Health Organization, of the 115 people in four Asian countries who have been infected with H5N1 from late 2003 through 2005, 59 have died. Vaccines are the principal medical intervention for protecting individuals against pandemic influenza. If available rapidly and in sufficient quantities, they can reduce the morbidity and mortality in pandemic situations.

According to a news posted on Sept 28, 2005, government scientists at the US National Institute of Allergy and Infectious Diseases (NIAID) announced results from initial clinical trials of a vaccine being developed to protect humans against infection with H5N1 avian influenza. NIAID and MedImmune have joined forces to develop potential pandemic influenza vaccines. HHS Secretary Mike Leavitt today announced that NIAID and MedImmune Inc. have signed a cooperative research and development agreement for the development of vaccines against avian influenza viruses that have the potential to cause pandemics. Speaking of pandemic flu as an urgent health challenge, HHS

Secretary Mike Leavitt said. “This agreement will help speed the process of developing vaccines we will need to fight an outbreak if the avian flu starts to spread rapidly through the human population.” As per the agreement, scientists will add selected genes from avian flu viruses with pandemic potential into a weakened human flu virus to create several attenuated, live virus v accines candidates.

Although there has been an incredible and alarming rise in human cases of bird flu, causing increasing fear of a global pandemic, there seems to be a strong resolve in the scientific community to combat this impending and much dreaded pandemic.
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... Eating Recovery Center, Washington ... opening a brand new child and adolescent residential treatment center on June 1. ... even more specialized eating disorder treatment and access to life-saving care. , To ...
(Date:5/26/2016)... ... May 26, 2016 , ... American orthopedic surgeon ... officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International ... May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was focused on ...
(Date:5/26/2016)... ... , ... Bunion Bootie , the manufacturer of the newest and best ... by customer demand over the Mother’s Day Weekend promotion. So much so, that they ... has completely replenished its inventory levels, it hopes to continue its current sales pace, ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our professional athletes ... YOUR HEAD ™”. , “We are proud to introduce Meghan Klingenberg, defender ... we have Brian Quick, wide receiver for Los Angeles who was a second round ...
(Date:5/26/2016)... , ... May 26, 2016 , ... May 2016 – ... so central to popular cosmetic improvement efforts. Record numbers of clients now ask about ... prominent or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
Breaking Medicine Technology: